RDARS - RDARS' Eagle Eye drone.
RDARS' Eagle Eye drone.
Source: RDARS.

Since artificial intelligence (AI) reached global notoriety because of ChatGPT and Google Bard, and their seamless ability to expedite creative and analytical tasks, the stock market has been inundated with companies offering value-added technologies in the space.

From healthcare to security and customer analytics, investors have a generational opportunity to invest in AI’s immense data-processing power, which can identify patterns exponentially quicker and cheaper than human cognition alone, and increase shareholder value by remaining at the leading edge of technological development.

Stockhouse sat down with executives behind three standout artificial intelligence stocks this past week, each of which is firmly on the path towards sustained long-term growth:

NetraMark Holdings

NetraMark Holdings (CSE:AIAI) builds proprietary machine-learning algorithms for health care professionals to extract insights from multimodal datasets related to efficacy, toxicity and placebo response.

The company’s flagship product, NetraAI, is designed to streamline and strengthen clinical trials through highly detailed breakdowns of patient populations.

Supported by a management team of healthcare stalwarts, NetraMark is focused on improving clinical trials’ 12 per cent success rate through its technology’s superhuman facility with data.

To this end, the artificial intelligence stock recently signed a master services agreement with a large biopharmaceutical company to analyze clinical trial data from select candidate medicines.

CEO George Achilleos spoke with Stockhouse’s Brieanna McCutcheon about the news.

NetraMark stock (CSE:AIAI) has fallen by around 88 per cent since 2018, though it has added 80.56 per cent year to date as AI becomes table stakes across the healthcare landscape.

Continue your due diligence by reading NetraMark Holdings’ latest investor presentation.

RDARS (Real-Time Drone Alarm Response System)

Our next artificial intelligence stock pick is RDARS (CSE:RDRS), an autonomous robotics and drone technology company advancing the quality of residential, commercial and industrial security.

RDARS’ flagship Eagle Watch System includes a drone and a ground-based robot that uses AI to identify where an alarm is triggered, travel to that location and collect video evidence, which they can transmit to authorities in real time.

The early stage company, which reported its first revenue in Q3 2023, has been fielding an increasing number of inquiries catalyzed by its first Beyond Visual Line of Sight certificate. The certificate unlocks key use cases for the Eagle Watch System, including deliveries and extensive automated patrols.

CEO Charles Zwebner joined Stockhouse’s Ryan Dhillon to explain the significance of RDARS transitioning from a development to a revenue-producing company.

RDARS stock (CSE:RDRS) is down by 70 per cent over the past year, but has gained 125 per cent over the past month, indicating that the tides might be turning for this microcap artificial intelligence stock as word spreads about its differentiated technology.

Liberty Defense Holdings

Liberty Defense Holdings (TSXV:SCAN) offers AI-based walkthrough threat detection technology designed to screen for firearms, explosives and other weapons in high-traffic areas.

Liberty’s flagship HEXWAVE product, licensed from the Massachusetts Institute of Technology (MIT), provides discrete, modular and scalable detection of metallic and non-metallic weapons.

The company also holds licenses for millimetre wave-based high-definition advanced imaging for body and shoe scanning. Both technologies were developed by researchers at the Pacific Northwest National Laboratory and funded by the U.S. Department of Homeland Security Science and Technology Directorate.

New revenue has been ramping up for Liberty Defense as of late, including its initial European deployment, orders from Los Alamos National Laboratory and the Greater Toronto Airport Authority, and a $3.8 million contract from the U.S. Transportation Security Administration (TSA) to improve its open architecture and high-definition advanced imaging capabilities.

CEO Bill Frain joined Stockhouse’s Brieanna McCutcheon to discuss the new TSA contract.

With mass shootings up by over 66 per cent in the United States since 2019, and the TSA confiscating a record number of guns in 2022, Liberty Defense offers exposure to a modern-day essential service backed by the constant demand for peace of mind.

Liberty Defense stock (TSXV:SCAN) has lost 7.5 per cent year-over year and 89.18 per cent since 2018, suggesting a disconnect between the average investor and the company’s solidifying presence in a growing US$37 billion market.

Learn more by reading Liberty Defense Holdings’ latest investor presentation.

Join the discussion: Find out what everybody’s saying about these artificial intelligence stocks on the NetraMark, RDARS and Liberty Defense Bullboards, and check out Stockhouse’s stock forums and message boards.

This is sponsored content issued on behalf of NetraMark Holdings, RDARS and Liberty Defense Holdings, please see full disclaimer here.


More From The Market Online

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

New Canadian drone made exclusively for military operations

Draganfly (CSE:DPRO) launches its newest product, the FlexForce Modular FPV system, exclusively to government and military buyers.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.